Ozempic vs Wegovy for weight loss: which do online clinics prescribe more easily?

Short answer

• Online clinics generally find it easier to prescribe Ozempic (semaglutide for diabetes) off‑label for weight loss than to prescribe Wegovy (the FDA‑approved high‑dose semaglutide for weight management). Wegovy is the labeled obesity medication and tends to have stricter eligibility, more limited supply/insurance controls, and higher cost—so fewer providers will prescribe it casually.

Why (brief)

• Wegovy is approved specifically for chronic weight management and vendors/insurers often require BMI thresholds, documentation, prior authorization, and closer follow‑up.
• Ozempic is approved for type 2 diabetes but contains the same active drug (semaglutide) at lower doses; many telehealth services prescribe it off‑label for weight loss because it’s often easier to obtain and cheaper than Wegovy.
• Supply shortages and company policies also shape what clinics will offer.

How this plays out at online clinics (examples)

• Calibrate — A specialized weight‑loss telemedicine program that markets a comprehensive metabolic program and is known to prescribe FDA‑approved obesity medications (including Wegovy when clinically appropriate). Good if you want a structured program plus the labelled drug.
• Profile by Sanford — a clinic/program focused on medical weight management that will pursue approved obesity medications and works with insurance/authorization processes.
• Hims & Hers — a large consumer telehealth provider that commonly offers semaglutide programs and is more likely to prescribe semaglutide (often using available formulations) for weight loss; convenient and consumer‑facing.
• Ro / Rory — Ro’s telehealth services (including Rory for women’s health) have offered semaglutide prescriptions for weight loss; tends toward pragmatic access options.
• PlushCare / Lemonaid / GoodRx Care (HeyDoctor) — general telehealth clinics that have listed semaglutide offerings; they may be more likely to offer off‑label prescriptions (including Ozempic) depending on clinician judgment and supply.

What to do next

• Check each clinic’s page for “Wegovy” or “semaglutide” — many will state whether they prescribe Wegovy specifically or semaglutide off‑label.
• Ask upfront: do you prescribe Wegovy (2.4 mg) vs. Ozempic (off‑label)? What are eligibility criteria, costs, and monitoring plans? Will you handle labs and follow‑up?
• If you want the FDA‑approved route and insurance coverage, focus on specialized weight‑management programs (Calibrate, Profile) or your primary care/weight clinic and be prepared for prior authorization. If you want faster/cheaper access and accept off‑label prescribing, larger telehealth providers (Hims & Hers, Ro, PlushCare, Lemonaid) are more likely to help.

Safety note

• Discuss medical history, pregnancy risk, pancreatic/biliary history, and other meds with a clinician. Weight‑loss use of GLP‑1s needs appropriate monitoring.